Trisha Shetty (Editor)

Tefibazumab

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Type
  
Whole antibody

ATC code
  
none

Source
  
Humanized (from mouse)

Trade names
  
Aurexis

CAS Number
  
521079-87-8

Tefibazumab (named Aurexis but not approved) is a humanized monoclonal antibody for the treatment of severe infections with Staphylococcus aureus. Possible indications include the treatment of S. aureus in a phase 2a patients with cystic fibrosis and of methicillin-resistant S. aureus.

It was developed by Inhibitex.

References

Tefibazumab Wikipedia


Similar Topics